Compare State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF (FLRN) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF vs DENTSPLY SIRONA Inc — how do they compare? State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.79, while DENTSPLY SIRONA Inc trades at $14 (market cap $2.68B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF pays none. Which is the better fit depends on your goals.
| FLRN | XRAY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $30.86 | $16.85 |
52-Week Low | $30.65 | $9.64 |
Market Cap | — | $2.68B |
Enterprise Value | — | $4.83B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLRN trades at $30.79 with no price movement in the last 24 hours. The technical picture shows a bearish trend with moving averages indicating selling pressure, though oscillators are neutral. Key financial ratios including P/E, P/S, and ROE are unavailable in the current data. Recent corporate actions include three dividend payments of $0.11 each scheduled for mid-2026, suggesting management's commitment to shareholder returns despite the current technical weakness.
The outlook for FLRN appears cautious with bearish technical signals dominating. The stock faces headwinds from the current market environment where inflation concerns are driving investors toward inflation-protected assets. Investment opportunities exist in the consistent dividend payments, but risks include the overall bearish technical setup and potential pressure from rising interest rates that could impact stock valuations broadly.
XRAY trades at $13.76, up 8.35% in 24 hours, with technical indicators showing a bullish trend. The stock has missed earnings estimates for three consecutive quarters, with Q2 2026 EPS expected at $0.36. Revenue declined to $3.68 billion in 2025, and the company reported a net loss of $598 million. Recent news highlights include distribution expansions and new AI-enabled product launches, while analyst sentiment remains mixed with a consensus price target of $13.33.
The outlook for XRAY is cautious due to persistent earnings misses and negative profitability, though technical momentum and strategic initiatives offer some upside potential. Key risks include margin pressure, high debt levels, and soft European demand. Investors should weigh the bullish technical signals against fundamental weaknesses before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF
FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
